ZA871788B - Iron containing composition and method for treating cancer - Google Patents

Iron containing composition and method for treating cancer

Info

Publication number: ZA871788B
Authority: ZA; South Africa
Prior art keywords: gamma; linolenic acid; treating cancer; containing composition; acids
Prior art date: 1986-03-21

Application number

ZA871788A

Other languages

English (en)

Inventor

David Frederick Horrobin

Frederick Horrobin David

Michel Edgar Begin

Edgar Begin Michel

Original Assignee

Efamol Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-21

Filing date

1987-03-12

Publication date

1987-10-28

1987-03-12 Application filed by Efamol Ltd filed Critical Efamol Ltd

1987-10-28 Publication of ZA871788B publication Critical patent/ZA871788B/xx

Links

XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 4
229910052742 iron Inorganic materials 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
239000002253 acid Substances 0.000 abstract 2
150000007513 acids Chemical class 0.000 abstract 2
VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 2
235000020664 gamma-linolenic acid Nutrition 0.000 abstract 2
VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 2
229960002733 gamolenic acid Drugs 0.000 abstract 2
150000002506 iron compounds Chemical class 0.000 abstract 2
HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 1
235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 1
JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 1
HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
229960005135 eicosapentaenoic acid Drugs 0.000 abstract 1
JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 1
235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 1
235000004626 essential fatty acids Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)

ZA871788A 1986-03-21 1987-03-12 Iron containing composition and method for treating cancer ZA871788B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868607137A GB8607137D0 (en)	1986-03-21	1986-03-21	Compositions

Publications (1)

Publication Number	Publication Date
ZA871788B true ZA871788B (en)	1987-10-28

Family

ID=10595060

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA871788A ZA871788B (en)	1986-03-21	1987-03-12	Iron containing composition and method for treating cancer

Country Status (12)

Country	Link
US (1)	US5128152A (de)
EP (1)	EP0246734B1 (de)
JP (1)	JP2574153B2 (de)
AT (1)	ATE60508T1 (de)
AU (1)	AU595012B2 (de)
CA (1)	CA1287297C (de)
DE (1)	DE3767763D1 (de)
ES (1)	ES2033831T3 (de)
GB (1)	GB8607137D0 (de)
GR (1)	GR3001473T3 (de)
IE (1)	IE59635B1 (de)
ZA (1)	ZA871788B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5246726A (en) *	1986-03-21	1993-09-21	Efamol Ltd.	Iron-containing composition and method for treatment of cancer
US5759837A (en) *	1989-01-17	1998-06-02	John Hopkins University	Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5665874A (en) *	1989-01-17	1997-09-09	John Hopkins University	Cancer related antigen
US5759791A (en) *	1989-01-17	1998-06-02	The Johns Hopkins University	Cancer related antigen
US5264217A (en) *	1990-01-30	1993-11-23	Efamol Holdings Ltd.	Method of increasing the total fat content of milk
DE69013139T2 (de) *	1990-03-13	1995-05-18	Riha	Mittel zur Vorbeugung, Diagnose und Therapie von rheumatischen, autoimmunen, Haut- und Bindegewebekrankheiten von unbekannter Aetiologie und Verfahren zu seiner Herstellung und Verwendung.
NO168152L (no) *	1990-05-23	1991-10-14	Norsk Hydro As	Fiskefôr
GB2254556B (en) *	1991-04-11	1995-04-12	Fisons Plc	Formulations containing linolenic acid
EP0651636B1 (de) *	1992-07-24	2002-10-02	The Johns Hopkins University	Verwendung von inhibitoren der synthese von fettsäuren zur behandlung von krebs
US5614551A (en) *	1994-01-24	1997-03-25	The Johns Hopkins University	Inhibitors of fatty acid synthesis as antimicrobial agents
DE4419256A1 (de) *	1994-06-01	1995-12-07	Rau Freiherr Von Nagell Helmut	Verwendung von intravenös applizierbarem Eisen zur Therapie von Tumorerkrankungen und/oder Infektionskrankheiten
US5981575A (en) *	1996-11-15	1999-11-09	Johns Hopkins University, The	Inhibition of fatty acid synthase as a means to reduce adipocyte mass
MXPA02011092A (es)	2000-05-10	2004-08-19	David A Sirbasku	Composiciones y metodos para demostrar la regulacion del sistema inmune secretor del crecimiento de la celula de cancer que responde a la hormona esteroidea.
US20030072812A1 (en)	2001-05-10	2003-04-17	Sirbasku David A	Breast cancer eradication program
EP2299265A1 (de) *	2001-11-13	2011-03-23	Signe BioPharma Inc.	Krebsausrottungsprogramm
CA2436650A1 (en) *	2003-08-06	2005-02-06	Naturia Inc.	Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3911117A (en) *	1971-12-20	1975-10-07	Fredrik Ender	Raw fish and iron chelated with glutamic or ribonucleic acid in a mink diet
DE2967049D1 (en) *	1978-04-11	1984-07-19	Efamol Ltd	Pharmaceutical and dietary composition comprising gamma-linolenic acids
EP0092076B1 (de) *	1982-04-16	1986-12-17	Societe Des Produits Nestle S.A.	Lipidhaltige Zusammensetzung für die orale, enterale oder parenterale Ernährung
GB8302708D0 (en) *	1983-02-01	1983-03-02	Efamol Ltd	Pharmaceutical and dietary composition
US4526902A (en) *	1983-10-24	1985-07-02	Century Laboratories, Inc.	Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
US4745099A (en) *	1985-02-06	1988-05-17	Chugai Seiyaku Kabushiki Kaisha	Pharmaceutical composition for the treatment of the anemia of malignant tumors

1986
- 1986-03-21 GB GB868607137A patent/GB8607137D0/en active Pending
1987
- 1987-03-11 IE IE63887A patent/IE59635B1/en not_active IP Right Cessation
- 1987-03-12 ZA ZA871788A patent/ZA871788B/xx unknown
- 1987-03-18 AT AT87302323T patent/ATE60508T1/de not_active IP Right Cessation
- 1987-03-18 ES ES198787302323T patent/ES2033831T3/es not_active Expired - Lifetime
- 1987-03-18 EP EP87302323A patent/EP0246734B1/de not_active Expired - Lifetime
- 1987-03-18 JP JP62061422A patent/JP2574153B2/ja not_active Expired - Lifetime
- 1987-03-18 DE DE8787302323T patent/DE3767763D1/de not_active Expired - Fee Related
- 1987-03-19 AU AU70181/87A patent/AU595012B2/en not_active Ceased
- 1987-03-20 CA CA000532606A patent/CA1287297C/en not_active Expired - Fee Related
1991
- 1991-02-13 GR GR91400184T patent/GR3001473T3/el unknown
- 1991-06-03 US US07/711,104 patent/US5128152A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE60508T1 (de)	1991-02-15
IE59635B1 (en)	1994-03-09
EP0246734A1 (de)	1987-11-25
JP2574153B2 (ja)	1997-01-22
US5128152A (en)	1992-07-07
ES2033831T3 (es)	1993-04-01
AU595012B2 (en)	1990-03-22
EP0246734B1 (de)	1991-01-30
GB8607137D0 (en)	1986-04-30
JPS62226923A (ja)	1987-10-05
IE870638L (en)	1987-09-21
CA1287297C (en)	1991-08-06
GR3001473T3 (en)	1992-10-08
DE3767763D1 (de)	1991-03-07
AU7018187A (en)	1987-09-24

Publication	Publication Date	Title
ZA871788B (en)	1987-10-28	Iron containing composition and method for treating cancer
GB8524276D0 (en)	1985-11-06	Pharmaceutical & dietary compositions
DE3571200D1 (en)	1989-08-03	Use of copper and fatty acids
EP0440307A3 (de)	1991-08-28	Pharmazeutische und diätetische Zusammensetzung
GB8319073D0 (en)	1983-08-17	Fatty acid compositions
PH24867A (en)	1990-12-26	A method of treating conditions associated with photodamaged skin by using pharmaceutical compositions containing p(22-(5,6,7,8 tetrahydro-5,5,8,8-tetramethyl-2-naphtyl)propenyl)phenylsulfone and derivatives thereof
GB8524275D0 (en)	1985-11-06	Pharmaceutical & dietary compositions
JPS6422819A (en)	1989-01-25	Amnesia treating or preventing composition
SE8901041D0 (sv)	1989-03-23	Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning
DE3366506D1 (en)	1986-11-06	Pharmaceutical composition
ZA861459B (en)	1986-11-26	Pharmaceutical and dietary compositions
IL98389A0 (en)	1992-07-15	3,3'-dithiobis(propionic acids),esters thereof and pharmaceutical compositions containing them
SE8800988D0 (sv)	1988-03-18	Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same
IE861744L (en)	1987-01-04	Composition for treatment of premenstrual syndrome
AU560756B2 (en)	1987-04-16	Composition containing an essential fatty acid and brotin
EP0537634A3 (de)	1994-05-04
DE2963545D1 (en)	1982-10-07	Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation